alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
COURT OF APPEALS EIGHTH DISTRICT OF TEXAS EL PASO, TEXAS

PRINCETON CAPITAL CORPORATION

,
Appellant

,

v.

KEITH W. SMITH and PARKVIEW CAPITAL CREDIT INC.

,
Appellee s

. §

§

§

§

§ No. 08

- 2 4

- 000 46

- CV

Appeal from the

131st Judicial D istrict Court

o f Bexar County, Texas

(TC# 2021CI02979 )

MEMORANDUM OPINION

This appeal is before the Court on its own motion to determine whether it should be

dismissed

. See T EX

. R. A PP

. P. 42.3

.

On March 1 2 , 202 4 , the Clerk of this Court sent Appellant a letter requesting payment of

the required filing fee and notifying Appellant that its notice of appeal appeared to be untimely

.

See T EX

. R. A PP

. P. 5 (requiring payment of fees in civil cases unless a party is e xcused by statute

or by appellate rules from paying costs). The letter notified Appellant that its appeal would be

subject to dismissal on or after ten days of the date of the notice unless Appe llant (1) tendered the

filing fee or evidence that it was excused from paying the required fee ; and (2) demonstrate d that

this Court ha d jurisdiction over the appeal. See T EX

. R. A PP

. P. 42.3 (a)

– (c) (authorizing an

appellate court to dismiss an appeal when the court lacks jurisdiction, where an appellant fails to2 prosecute the appeal, and where an appellant fails to comply with a notice from the clerk requiring

a response or other action within a spe cified time).

As of this date, which is more than ten days after the date of the notice, Appellant has not

responded to this Court’s notice on either point

. Accordingly , we dismiss this appeal. See T EX

. R.

A PP

. P. 5, 43.3 (a)

– (c)

.

GINA M. PALAFOX

, Justice

March 28, 2024

Before Alley , C.J., Palafox and Soto, JJ.
Amendment to Employment Agreement between the Company and Michael F. Brigham



 IMMUCELL CORPORATION 
 EXHIBIT 10.6 
 AMENDMENT TO EMPLOYMENT AGREEMENT 

 IMMUCELL CORPORATION, a Delaware corporation (the “Company”), and MICHAEL F. BRIGHAM, an individual residing in
Kennebunk, Maine (“Brigham”), hereby agree as follows as of this 26th day of March 2010. 
 1.        This agreement supersedes and replaces in its entirety the Employment Agreement, dated as of April 29, 1999, between the Company and Brigham. This agreement, together with the
Confidential Information, Inventions and Noncompete Agreement, dated of even date herewith, between the Company and Brigham and any stock option agreements previously entered into between the Company and Brigham, constitute the parties’ entire
understanding with respect to Brigham’s employment by the Company. 
 2.        Brigham shall serve as President and Chief Executive Officer of the Company in an “at will” capacity on such terms as the Board of Directors of the Company may from time to time
determine, subject to termination by the Board of Directors of the Company at any time, with or without cause. 
 IN WITNESS
WHEREOF, the parties hereto have executed this Agreement, intending the same to take effect as a sealed instrument, as of the date first above written. 
  

			
	IMMUCELL CORPORATION
		
	By:	 	/s/ Linda Rhodes
		 	 Dr. Linda Rhodes

		 	 Chair of Compensation and

		 	 Stock Option Committee

		
	/s/ 	 	Michael F. Brigham
	Michael F. Brigham
```

[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2620 Engrossed in House (EH)]

114th CONGRESS
  1st Session
                                H. R. 2620

_______________________________________________________________________

                                 AN ACT

 
To amend the United States Cotton Futures Act to exclude certain cotton 
            futures contracts from coverage under such Act.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. EXCLUDING CERTAIN COTTON FUTURES CONTRACTS FROM COVERAGE 
              UNDER UNITED STATES COTTON FUTURES ACT.

    (a) In General.--Subsection (c)(1) of the United States Cotton 
Futures Act (7 U.S.C. 15B(c)(1)) is amended--
            (1) by striking ``except that any cotton futures contract'' 
        and inserting the following: ``except that--
                    ``(A) any cotton futures contract'';
            (2) in subparagraph (A) (as designated by paragraph (1)), 
        by striking the period at the end and inserting ``; and''; and
            (3) by adding at the end the following new subparagraph:
                    ``(B) any cotton futures contract that permits 
                tender of cotton grown outside of the United States is 
                excluded from the coverage of this paragraph and 
                section to the extent that the cotton grown outside of 
                the United States is tendered for delivery under the 
                cotton futures contract.''.
    (b) Application.--The amendments made by subsection (a) shall apply 
with respect to cotton futures contracts entered into on or after the 
date of the enactment of this Act.

            Passed the House of Representatives June 23, 2015.

            Attest:

                                                                 Clerk.
114th CONGRESS

  1st Session

                               H. R. 2620

_______________________________________________________________________

                                 AN ACT

To amend the United States Cotton Futures Act to exclude certain cotton 
            futures contracts from coverage under such Act.
```
ContiFinancial Corporation
Calculation of Earnings Per Share
For the three months ended September 30, 1999


<TABLE>
<CAPTION>
<S>                                                                     <C>
Basic and Diluted Computation for the three months ended September 30,1999

Weighted average shares outstanding:

  Common stock excluding shares relating to employee incentive plans       45,720,925

  Vested Restricted Shares Outstanding during the Quarter                     746,770
                                                                        -------------
Weighted Average Shares Outstanding                                        46,467,695
                                                                        -------------
Quarter income (loss)                                                       ($335,707)
                                                                        -------------
Basic and Diluted Earnings Per Share                                           ($7.18)
                                                                        =============
</TABLE>
EXHIBIT 23.2

NOTICE REGARDING CONSENT OF ARTHUR ANDERSEN LLP

On
June 28, 2002, Edgewater Technology, Inc. (the "Company") terminated the engagement of Arthur Andersen LLP as its independent accountants as Arthur Andersen LLP's offices in the State
of Massachusetts were closed effective June 30, 2002. The decision to terminate Arthur Andersen LLP was approved by the Company's Audit Committee and the Company's Board of Directors. As
recommended by the Audit Committee of the Company's Board of Directors, the Board of Directors of the Company authorized and approved the Company's engagement of Deloitte & Touche LLP as its
new independent accountants to serve as the Company's independent accountants for the 2002 fiscal year. Deloitte & Touche LLP's engagement became effective as of June 28, 2002, the date
on which Deloitte & Touche LLP accepted the appointment.

Arthur
Andersen LLP was the Company's independent accountants. As a result of the closing of Arthur Andersen LLP ("Andersen"), we were unable to obtain the consent of Andersen to the incorporation by
reference in our registration statements on Form S-8 No. 333-50912 filed with the SEC on November 30, 2000 and Form S-8
No. 333-88313 filed with the SEC on October 1, 1999 of the audit report of Andersen with respect to our financial statements as of December 31, 2001 and for the fiscal
years ended December 31, 2001 and 2000. We have dispensed with the requirement under Section 7 of the Securities Act to file the consent of Andersen in reliance on Rule 437(a)
under the Securities Act of 1933, as amended (the "Securities Act"). Because Andersen has not consented to the incorporation by reference of their report in the registration statements identified
above, purchasers of securities offered pursuant to those registration statements on or after the filing of this Form 10-K will not be able to recover against Andersen under
Section 11 of the Securities Act for any untrue statements of a material fact contained in the financial statements audited by Andersen and incorporated by reference in those financial
statements or any omissions to state a material fact required to be stated in those financial statements.

---

QuickLinks
|Exhibit 32


CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


Each of the undersigned hereby
certifies, in his capacity as an officer of Coast Casinos, Inc. (the Company),
for purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that to his knowledge:
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | o | the Quarterly Report of the Company on Form 10-Q for the period ended September 30, 2003 fully
complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of
1934; and
| | - | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | o | the information contained in such report fairly presents, in all material respects, the
financial condition and results of operation of the Company.
| | - | ----------------------------------------------------------------------------------------------------------------------------------------------------

Dated: November 13, 2003

|                                                                   | 
|------------------------------------------------------------------ | 
|/s/ Michael J. Gaughan                                             | 
|Michael J. GaughanChairman of the Board andChief Executive Officer | 
|/s/ Gage Parrish                                                   | 
|Gage ParrishVice President andChief Financial Officer              | 

|A signed original of this written
statement required by Section 906 has been provided to Coast Casinos, Inc. and will be
retained by Coast Casinos, Inc. and furnished to the Securities and Exchange Commission or
its staff upon request.
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
CERTIFICATION

I, Timothy B. Murphy, certify that:


5.   I have reviewed this quarterly report on Form 10-Q of Investors Capital
     Holdings, Ltd.;

6.   Based on my knowledge, this quarterly report does not contain any untrue
     statement of a material fact or omit to state a material fact necessary to
     make the statements made, in light of the circumstances under which such
     statements were made, not misleading with respect to the period covered by
     this quarterly report;

7.   Based on my knowledge, the financial statements, and other financial
     information included in this quarterly report, fairly present in all
     material respects the financial condition, results of operations and cash
     flows of the registrant as of, and for, the periods presented in this
     quarterly report;

8.   The registrant's other certifying officers and I are responsible for
     establishing and maintaining disclosure controls and procedures (as defined
     in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

     d)   designed such disclosure controls and procedures to ensure that
          material information relating to the registrant, including its
          consolidated subsidiaries, is made known to us by others within those
          entities, particularly during the period in which this quarterly
          report is being prepared;

     e)   evaluated the effectiveness of the registrant's disclosure controls
          and procedures as of a date within 90 days prior to the filing date of
          this quarterly report (the "Evaluation Date"); and

     f)   presented in this quarterly report our conclusions about the
          effectiveness of the disclosure controls and procedures based on our
          evaluation as of the Evaluation Date;

7.   The registrant's other certifying officers and I have disclosed, based on
     our most recent evaluation, to the registrant's auditors and the audit
     committee of registrant's board of directors (or persons performing the
     equivalent function):

     c)   all significant deficiencies in the design or operation of internal
          controls which could adversely affect the registrant's ability to
          record, process, summarize and report financial data and have
          identified for the registrant's auditors any material weaknesses in
          internal controls; and

     d)   any fraud, whether or not material, that involves management or other
          employees who have a significant role in the registrant's internal
          controls; and

8.   The registrant's other certifying officers and I have indicated in this
     quarterly report whether or not there were significant changes in internal
     controls or in other factors that could significantly affect internal
     controls subsequent to the date of our most recent evaluation, including
     any corrective actions with regard to significant deficiencies and material
     weaknesses.

Date: February 17, 2004

By: /s/ TIMOTHY B. MURPHY
--------------------------
Timothy B. Murphy
Chief Financial Officer




                                       23
<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          SEP-30-1998
<PERIOD-START>                             OCT-01-1997
<PERIOD-END>                               MAR-31-1998
<CASH>                                      35,098,000
<SECURITIES>                                27,865,000
<RECEIVABLES>                               18,249,000
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            85,711,000
<PP&E>                                      27,902,000
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                             123,892,000
<CURRENT-LIABILITIES>                       53,143,000
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         2,000
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>               123,892,000
<SALES>                                     90,184,000
<TOTAL-REVENUES>                            90,184,000
<CGS>                                       39,017,000
<TOTAL-COSTS>                               39,017,000
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               9,000
<INCOME-PRETAX>                              5,159,000
<INCOME-TAX>                                 1,754,000
<INCOME-CONTINUING>                          3,405,000
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 3,405,000
<EPS-PRIMARY>                                     0.15
<EPS-DILUTED>                                     0.15
        

</TABLE>
#### Mayor of the City of New York, Appellant, v Council of the City of New York, Respondent. Lillian Roberts, as Executive Director of District Council 37, AFSCME, AFL-CIO, et al., Intervenors-Respondents.

Submitted March 26, 2007;

decided March 29, 2007

Motion by New York State County Executives’ Association for leave to file a brief amicus curiae on the appeal herein granted. Two copies of the brief may be served and 24 copies filed within seven days.
[Federal Register Volume 65, Number 75 (Tuesday, April 18, 2000)]
[Notices]
[Pages 20825-20826]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-9580]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. 79N-0113; DESI 2847]


Pediatric Parenteral Multivitamin Products; Drug Efficacy Study 
Implementation; Announcement of Marketing Conditions; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
that appeared in the Federal Register of January 26, 2000 (65 FR 4253). 
The document announced the conditions for marketing pediatric 
parenteral multivitamin drug products for the indications for which 
they are

[[Page 20826]]

now regarded as effective. The document was published with an 
inadvertent error. This document corrects that error.

FOR FURTHER INFORMATION CONTACT: Mary E. Catchings, Center for Drug 
Evaluation and Research (HFD-7), Food and Drug Administration, 5600 
Fishers Lane, Rockville, MD 20857, 301-594-2041.

SUPPLEMENTARY INFORMATION: In FR Doc. 00-1787 appearing on page 4253 in 
the Federal Register of Wednesday, January 26, 2000, the following 
correction is made:
    On page 4255, in the first column, in paragraph B.2.(a), beginning 
in the second line, the sentence ``Caution: Federal law prohibits 
dispensing without prescription'' is corrected to read ``Rx only.''
    This change is made in accordance with section 126(a) of the Food 
and Drug Modernization Act of 1997. Section 126(a) modified section 
503(b)(4) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
353(b)(4)).

    Dated: April 7, 2000.
William K. Hubbard,
Senior Associate Commissioner for Policy, Planning, and Legislation.
[FR Doc. 00-9580 Filed 4-17-00; 8:45 am]
BILLING CODE 4160-01-F
```

[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2559 Referred in Senate (RFS)]

114th CONGRESS
  1st Session
                                H. R. 2559

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             June 16, 2015

 Received; read twice and referred to the Committee on Environment and 
                              Public Works

_______________________________________________________________________

                                 AN ACT

 
To designate the ``PFC Milton A. Lee Medal of Honor Memorial Highway'' 
                         in the State of Texas.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. DESIGNATION.

    The segment of Interstate Route 10 between milepost 535 and 
milepost 545 at Kendall County, Texas, shall be known and designated as 
the ``PFC Milton A. Lee Medal of Honor Memorial Highway''.

SEC. 2. REFERENCES.

    Any reference in a law, map, regulation, document, paper, or other 
record of the United States to the segment of Interstate Route 10 
referred to in section 1 shall be deemed to be a reference to the ``PFC 
Milton A. Lee Medal of Honor Memorial Highway''.

            Passed the House of Representatives June 15, 2015.

            Attest:

                                                 KAREN L. HAAS,

                                                                 Clerk.
```
[No. 13682.

*En Banc.*

August 7, 1917.]

#### Z. A. Scouse *et al., Appellants,*v. Alaska & Yakima Investment Company *et al., Respondents.**1*

Appeal from a judgment of the superior court for Yakima county, Grady, J., entered July 29,1916, in favor of the defendants, dismissing an action to subject real property to the satisfaction of a judgment, tried to the court.

Affirmed.

*'Willett & Oleson, O. L. Willett,*and *Englehart & Rigg,*for appellants.

*H. J. Snively,*for respondents.

1

Reported in 166 Pac. 777.

On Rehearing.

Per Curiam.

Upon a rehearing *En Banc,*a majority of the court still adhere to the opinion heretofore filed herein as reported in 94 Wash. 250, 161 Pac. 1189, and for the reasons there stated, the judgment is affirmed.
# C_2021484EN.01000201.xml

| 2.12.2021 | EN | Official Journal of the European Union | C 484/2 |
| --- | --- | --- | --- |

2.12.2021

EN

Official Journal of the European Union

C 484/2

---

Non-opposition to a notified concentration

(Case M.10133 – ASTORG / NORDIC CAPITAL / NOVO / BIOCLINICA)

(Text with EEA relevance)

(2021/C 484/02)

On 22 April 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10133. EUR-Lex is the online point of access to European Union law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10133. EUR-Lex is the online point of access to European Union law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---